Cargando…

Improving the Efficacy of Regulatory T Cell Therapy

Autoimmunity is caused by an unbalanced immune system, giving rise to a variety of organ-specific to system disorders. Patients with autoimmune diseases are commonly treated with broad-acting immunomodulatory drugs, with the risk of severe side effects. Regulatory T cells (Tregs) have the inherent c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baeten, Paulien, Van Zeebroeck, Lauren, Kleinewietfeld, Markus, Hellings, Niels, Broux, Bieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256646/ https://www.ncbi.nlm.nih.gov/pubmed/34224053 http://dx.doi.org/10.1007/s12016-021-08866-1

Ejemplares similares

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
por: Verreycken, Janne, et al.
Publicado: (2022)

Oncostatin M, an Underestimated Player in the Central Nervous System
por: Houben, Evelien, et al.
Publicado: (2019)

When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4(+) T Cells
por: Hoeks, Cindy, et al.
Publicado: (2022)

Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity
por: Grajchen, Elien, et al.
Publicado: (2023)

Editorial: Neuro-Immune Connections to Enable Repair in CNS Disorders
por: Vanmierlo, Tim, et al.
Publicado: (2020)

Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells
por: Van Zeebroeck, Lauren, et al.
Publicado: (2021)

Treg-Resistant Cytotoxic CD4(+) T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation
por: Hoeks, Cindy, et al.
Publicado: (2021)

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
por: Peeters, Liesbet M., et al.
Publicado: (2017)

L-Arginine Depletion Improves Spinal Cord Injury via Immunomodulation and Nitric Oxide Reduction
por: Erens, Céline, et al.
Publicado: (2022)

Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
por: Claes, Nele, et al.
Publicado: (2014)

Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
por: Hermans, Doryssa, et al.
Publicado: (2023)

Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
por: Vanheusden, Marjan, et al.
Publicado: (2017)

Effects of Recombinant IL-13 Treatment on Gut Microbiota Composition and Functional Recovery after Hemisection Spinal Cord Injury in Mice
por: Hamad, Ibrahim, et al.
Publicado: (2023)

The Impact of Dietary Components on Regulatory T Cells and Disease
por: Arroyo Hornero, Rebeca, et al.
Publicado: (2020)

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023)

Innate Lymphoid Cells - Neglected Players in Multiple Sclerosis
por: Sadeghi Hassanabadi, Negar, et al.
Publicado: (2022)

Dissecting the role of CSF2RB expression in human regulatory T cells
por: Côrte-Real, Beatriz F., et al.
Publicado: (2022)

Clinical Manufacturing of Regulatory T Cell Products For Adoptive Cell Therapy and Strategies to Improve Therapeutic Efficacy
por: Baron, Kassandra J., et al.
Publicado: (2023)

Carnosine quenches the reactive carbonyl acrolein in the central nervous system and attenuates autoimmune neuroinflammation
por: Spaas, Jan, et al.
Publicado: (2021)

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
por: Willebrand, Ralf, et al.
Publicado: (2019)

Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy
por: Britsch, Isabel, et al.
Publicado: (2023)

CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis
por: Bogie, Jeroen FJ, et al.
Publicado: (2020)

Microglial derived extracellular vesicles activate autophagy and mediate multi‐target signaling to maintain cellular homeostasis
por: Van den Broek, Bram, et al.
Publicado: (2020)

Evolution of Evolvability in Gene Regulatory Networks
por: Crombach, Anton, et al.
Publicado: (2008)

Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells
por: Ravanidis, Stylianos, et al.
Publicado: (2017)

From transporter to transceptor: Signaling from transporters provokes re-evaluation of complex trafficking and regulatory controls: Endocytic internalization and intracellular trafficking of nutrient transceptors may, at least in part, be governed by their signaling function
por: Kriel, Johan, et al.
Publicado: (2011)

Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity
por: Binger, Katrina J., et al.
Publicado: (2017)

Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury
por: Mussen, Femke, et al.
Publicado: (2023)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Cell-Based Therapies with T Regulatory Cells
por: Gliwiński, Mateusz, et al.
Publicado: (2017)

Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies
por: Suuring, Maaike, et al.
Publicado: (2021)

T-Regulatory Cells In Tumor Progression And Therapy
por: Verma, Amit, et al.
Publicado: (2019)

Gut Microbiota and the Paradox of Cancer Immunotherapy
por: Poutahidis, Theofilos, et al.
Publicado: (2014)

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)
por: De Bondt, Mirre, et al.
Publicado: (2020)

Distinct Effector Programs of Brain-Homing CD8(+) T Cells in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2022)

Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
por: Roggeri, Alessandra, et al.
Publicado: (2020)

Anti-regulatory T cells are natural regulatory effector T cells
por: Ødum, Niels
Publicado: (2019)

Targeting inflammation to improve regulatory T cell therapy for immunopathologies
por: Salomon, Benoit L.
Publicado: (2022)

Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
por: Ait-Oufella, Hafid, et al.
Publicado: (2021)

Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
por: Churov, Alexey V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_54cadgpg56dkoedt27m4hr4cu0